Drugs Made In America Acquisition (DMII) Current Assets (2024 - 2025)

Drugs Made In America Acquisition (DMII) reported Current Assets of $26037.0 for Q4 2025, down 56.32% year-over-year from $59615.0 in Q4 2024, and down 97.1% quarter-over-quarter from $896356.0 in Q3 2025.

Drugs Made In America Acquisition (DMII) Current Assets (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has 2 years of Current Assets data on file, last reported at $26037.0 in Q4 2025.

  • Current Assets for Q4 2025 came in at $26037.0, down 56.32% year-over-year; the trailing twelve-month figure through Dec 2025 was $26037.0 (down 56.32% YoY), and the FY2025 annual result was $26037.0, down 56.32% from the prior year.
  • Current Assets eased to $26037.0 in Q4 2025 per DMII's latest filing, from $896356.0 in the prior quarter.
  • Over five years, Current Assets peaked at $896356.0 in Q3 2025 and troughed at $26037.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn - 1.58 Mn
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn - 188,111.00
3 Berto Acquisition 311.56 Mn 311.56 Mn - 405,162.00
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 280,749.00
5 Centurion Acquisition 310.21 Mn 310.21 Mn - 54,530.00
6 WEN Acquisition 309.15 Mn 309.15 Mn - 681,487.00
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn - 214,543.00
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn - 665,298.00
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn - 1.21 Mn
10 Drugs Made In America Acquisition 129.34 Mn 129.34 Mn - 26,037.00

Historic Data

Download Data
DateValue
Dec 31, 2025 26,037.00
Sep 30, 2025 896,356.00
Dec 31, 2024 59,615.00